← Back to Search

Behavioural Intervention

Father-Focused Programs for Reducing Domestic Violence (F4C Trial)

N/A

Recruiting

Led By Carla S Stover, PhD

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Current untreated psychotic disorder

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 19 weeks, 43 weeks and 70 weeks

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare two programs to see which is more effective in reducing family violence and improving child mental health in fathers with a history of Intimate Partner Violence.

Who is the study for?

This trial is for fathers with a history of intimate partner violence who have at least one child aged 6 months to 12 years. They must be involved in or recently investigated by CT DCF, agree to involve the child's mother as an informant, and be able to complete assessments in English. Fathers with active protective orders against their children, severe substance addiction needing detoxification, significant cognitive impairment, untreated psychotic disorders, or current suicidal/homicidal thoughts are excluded.

What is being tested?

The study compares 'Fathers for Change' (F4C) with standard Batterer Intervention Programs (BIP) to see which is better at reducing family violence and improving children's mental health. It will also examine how changes occur over time and if improvements in fathers' emotional regulation affect the outcomes for their children.

What are the potential side effects?

Since this trial involves psychological interventions rather than medications, traditional side effects like those seen with drugs are not expected. However, participants may experience emotional discomfort or distress when discussing sensitive topics related to family violence and personal behaviors.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a psychotic disorder that is not being treated.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 19 weeks, 43 weeks and 70 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 19 weeks, 43 weeks and 70 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 19 weeks, 43 weeks and 70 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Physical Child Maltreatment overtime

Change in Physical Intimate Partner Violence (IPV) overtime

Change in Verbal Child Maltreatment overtime

+1 more

Secondary study objectives

Change in Child Aggression Symptoms

Change in Child Anxiety Symptoms

Change in Child Depression Symptoms

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Fathers for ChangeExperimental Treatment1 Intervention

Defining features of F4C include: 1) focus on the fathering role to facilitate engagement, 2) focus on RF to understand self, partner and children and emotion regulation skills to reduce IPV and child maltreatment. F4C focuses on understanding of emotional experiences, how they impact thinking and behaviors related to partners, co-parents and children. F4C clients will meet individually with their F4C therapist for 60 minutes per week over 18 weeks.

Group II: Duluth BIPActive Control1 Intervention

The BIP is a psychoeducational intervention that will be delivered in 60- minute individual weekly sessions over 18 weeks. The intervention focuses on the impact of violence on victims, power and control tactics, and societal influences supporting men's violence toward women. The intervention includes didactics and experiential exercises including video vignettes and role plays to teach anger management skills.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Fathers for Change

2016

Completed Phase 2

~90

0 / 1Eligibility criteria met